Bartolome Celli, MD, professor of medicine at Tufts University and of St. Elizabeth Medical Center in Boston, Massachusetts, asked Dr. Mannino about ways to block cadmium from causing lung damage.

Dr. Celli, who was the principal investigator of one component of TORCH, is the head of pulmonary and critical care medicine at St. Elizabeth's Medical Center in Boston, Massachusetts.

All three are still highly experimental — the research is only for people who have run out of options, cautions Tufts University’s Dr. Bartolome Celli, who outlined the study trio at an ...

All three are still highly experimental — the research is only for people who have run out of options, cautions Dr. Bartolome Celli of Tufts University, who outlined the study trio at an ...

The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according ...

Celli said this is the first demonstration of an effective drug therapy in COPD. The rate of lung function decline was similar despite variables such as sex, age, ethnicity and body-mass index.

While the drug probably will not slow the deterioration of thelungs, many sufferers could see their overall well-being improve bybetween 30 and 50 percent, said Celli, who was not involved in ...

And if it turns out to be as good as it looks right now, it could improve the quality of life for nearly half of the 600 million people with the disease, said Dr. Bartolome Celli.

Natalia Dinorah Celli, daughter of Bartolome and Doris Celli of Wellesley, was married on Dec. 31, 2007, to Kyle Scott Bernhardt, son of Peter Bernhardt of Jericho, Vt., and Edie Bernhardt of ...

Maria, the daughter of Drs. Bartolome and Doris Celli, is a graduate of Wellesley High School, Class of 1996. She received a bachelor’s degree from Tufts University.

Newly-presented data from the TORCH trial of GlaxoSmithKline’s combination respiratory drug Advair/Seretide prove that the drug can improve survival in patients with chronic obstructive pulmonary ...